Sphere Fluidics Ltd

Sphere Fluidics, based in Cambridge (UK), offers a range of innovative cell encapsulation tools for single-cell analysis and isolation. Our proprietary picodroplet microfluidic platforms excel in single-cell screening and isolation while preserving cell viability. Our flagship product Cyto-Mine® provides an integrated system with the ability to select, manipulate, analyze, and isolate cells, through an easy to use and intuitive interface that can automatically screen up to 40 million cells in a matter of hours. This unrivaled throughput aids in the acceleration of biopharmaceutical discovery and development, cell therapy, and synthetic biology workflows, easing the journey of discovery in labs globally.